ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.047,79
0,85%
Dow Jones
43.950,01
1,06%
Euro vs US Dollar
1,04333
0,12%
Bitcoin
106.907,01
4,78%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. CTT Pharmaceutical Holdings Inc (PK) (CTTH) Börsenkurse

CTT Pharmaceutical Holdings Inc (PK)

CTT Pharmaceutical Holdings Inc (PK) (CTTH)

USOTC
0,1296
0,0537
( 70,75% )
Aktualisiert: 19:23:09
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,1296
Gebot
0,1179
Fragen
0,1413
Volumen
154.550
0,08 Tagesbereich 0,13
0,01 52-Wochen-Bereich 0,13
Marktkapitalisierung
6,271M
Handelsende
0,0759
Handelsbeginn
0,08
Letzte Trade
450
@
0.1296
Letzter Handelszeitpunkt
19:23:09
Finanzvolumen
US$ 15.487
VWAP
0,100205
Durchschnittliches Volumen (3 Mio.)
29.748
Ausgegebene Aktien
48.390.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-171,43
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-36k

Über CTT Pharmaceutical Holdings Inc (PK)

CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its technology... CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in major markets such as pain management. The Oral Thin Film (Wafer) formulation is protected by 3 Canadian, 2 U.S. patents and over 59 patents pending or granted worldwide. Mehr anzeigen

Sektor
Gold And Silver Ores
Branche
Gold And Silver Ores
Website
www.cttpharmaceuticals.com
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
CTT Pharmaceutical Holdings Inc (PK) is listed in the Gold And Silver Ores sector of the OTCMarkets with ticker CTTH. The last closing price for CTT Pharmaceutical (PK) was US$0,08. Over the last year, CTT Pharmaceutical (PK) shares have traded in a share price range of US$ 0,01 to US$ 0,13.

CTT Pharmaceutical (PK) currently has 48.390.000 shares in issue. The market capitalisation of CTT Pharmaceutical (PK) is US$3,67 million. CTT Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of -171.43.

CTTH Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

11 September 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

27 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

02 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Juli 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Oktober 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Oktober 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Oktober 2023
Edgar (US Regulatory)

MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing

  Live at MJAC 2017 Saturday 2nd September - 4.05 PM on Streaming Stage F How venture capital and cryptocurrency are converging as the future of cannabis investing ...

31 August 2017
InvestorsHub NewsWire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0985316.7202572350.03110.130.0311279350.07126346CS
40.08195171.9832109130.047650.130.03389350.06983472CS
120.069475115.5509355510.0601250.130.0184297480.06460746CS
260.086197.2477064220.04360.130.0184183050.06332703CS
520.0954278.9473684210.03420.130.01219610.04743289CS
1560.0946270.2857142860.0350.130.003300850.03852063CS
260-0.0504-280.180.260.003251010.05380443CS

CTTH - Frequently Asked Questions (FAQ)

What is the current CTT Pharmaceutical (PK) share price?
The current share price of CTT Pharmaceutical (PK) is US$ 0,1296
How many CTT Pharmaceutical (PK) shares are in issue?
CTT Pharmaceutical (PK) has 48.390.000 shares in issue
What is the market cap of CTT Pharmaceutical (PK)?
The market capitalisation of CTT Pharmaceutical (PK) is USD 3,67M
What is the 1 year trading range for CTT Pharmaceutical (PK) share price?
CTT Pharmaceutical (PK) has traded in the range of US$ 0,01 to US$ 0,13 during the past year
What is the PE ratio of CTT Pharmaceutical (PK)?
The price to earnings ratio of CTT Pharmaceutical (PK) is -171,43
What is the reporting currency for CTT Pharmaceutical (PK)?
CTT Pharmaceutical (PK) reports financial results in USD
What is the latest annual profit for CTT Pharmaceutical (PK)?
The latest annual profit of CTT Pharmaceutical (PK) is USD -36k
What is the registered address of CTT Pharmaceutical (PK)?
The registered address for CTT Pharmaceutical (PK) is 1100 - 1111 MELVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6E 3V6
What is the CTT Pharmaceutical (PK) website address?
The website address for CTT Pharmaceutical (PK) is www.cttpharmaceuticals.com
Which industry sector does CTT Pharmaceutical (PK) operate in?
CTT Pharmaceutical (PK) operates in the GOLD AND SILVER ORES sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
KBNTKubient Inc (CE)
US$ 0,0004
(39.900,00%)
10,21k
BWVIBlue Water Ventures International Inc (CE)
US$ 0,0004
(39.900,00%)
10k
CHWEChinawe Com Inc (CE)
US$ 0,0003
(29.900,00%)
1.000
ELYSElys BMG Group Inc (CE)
US$ 0,1002
(24.950,00%)
750
NBRVFNabriva Therapeutics PLC (CE)
US$ 0,0002
(19.900,00%)
127
OPESFOtello Corporation ASA (PK)
US$ 0,0001
(-99,98%)
1,05k
MTEMMolecular Templates Inc (CE)
US$ 0,000001
(-99,96%)
600
CTRYFCountry Garden Holdings Company Limited (CE)
US$ 0,0002
(-99,89%)
2,25k
CAUDCollective Audience Inc (CE)
US$ 0,0003
(-99,88%)
348
CNQQFClean TeQ Water Ltd (PK)
US$ 0,0007
(-99,88%)
300
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
142,54M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,00335
(1,52%)
77,92M
SPQSSportsQuest Inc (PK)
US$ 0,0004
(-20,00%)
61,49M
RONNRonn Motor Group Inc (PK)
US$ 0,0003
(-25,00%)
60,26M
GTVHGolden Triangle Ventures Inc (PK)
US$ 0,0004
(0,00%)
55,6M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
CTTH
CTT Pharmaceutical (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten